Our Mission

To find treatments and a cure for the rare cancer, Epithelioid Hemangioendothelioma (EHE), by advancing research and driving collaboration between patients, researchers, and clinicians.

Our Vision

We envision a world where Epithelioid Hemangioendothelioma (EHE) is easily diagnosed and treatable.

About Us

The EHE Foundation, founded in 2015, is a nonprofit 501c3 organization dedicated to pursuing effective treatment for Epithelioid Hemangioendothelioma (EHE) and supporting EHE patients and their families. EHE is a rare vascular sarcoma cancer that affects all age groups from children to elderly. Little is known about this cancer, which, in its aggressive form, is highly destructive and normally fatal.

Cancer is already tough, in every sense, but rare cancers like EHE have additional burdens of limited information, lack of solid research, and an absence of a standard treatment. EHE receives little funding for research and is not a priority for the research community.

Through grassroots fundraising and the deep involvement of an emerging and tight-knit global community, The EHE Foundation has been able to jump start promising research, launch a working group of worldwide experts, and create hope and urgency for thousands of patients and their families.

Thank you for being part of our EHE family.  We are amazed, inspired, and grateful that you continue to choose to stand alongside us in our commitment to fight EHE.  Your support helps us honor those we’ve lost by continuing to make progress in many facets of our foundation’s mission.